Lilly, 3rd-Party Payors Reach $4.5M Deal In Zyprexa Case

By Erin Fuchs (January 12, 2012, 7:28 PM EST) -- Eli Lilly & Co. secured approval Thursday of a $4.5 million settlement of claims brought by an insurer and five union health funds claiming they overpaid for the blockbuster antipsychotic drug Zyprexa because Lilly didn't reveal its adverse side effects.

U.S. District Judge Jack Weinstein approved the $4.5 million deal at a hearing in New York federal court Thursday, according to Lilly, which said that the settlement amount represented just a fraction of the estimated damages that the third-party payors had sought.

The third-party payor litigation was one of dozens of cases in multidistrict litigation alleging Lilly failed to reveal harmful...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!